The report presents a detailed analysis of the Carbapenemase diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
List of Tables
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
List of Tables
- France Carbapenemase Test Volume and Diagnostics Sales Forecast
- Germany Carbapenemase Test Volume and Diagnostics Sales Forecast
- Italy Carbapenemase Test Volume and Diagnostics Sales Forecast
- Japan Carbapenemase Test Volume and Diagnostics Sales Forecast
- Spain Carbapenemase Test Volume and Diagnostics Sales Forecast
- U.K. Carbapenemase Test Volume and Diagnostics Sales Forecast
- U.S.A. Carbapenemase Test Volume and Diagnostics Sales Forecast
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
